Sunday, April 14, 2024 | Baltimore, MD

Novavax to sell 1.5M more doses of its Covid vaccine to the U.S. government

February 14, 2023

Gaithersburg biotech Novavax Inc. (NASDAQ: NVAX) has reached an agreement to sell 1.5 million more doses of its Covid-19 vaccine to the U.S. government. Terms of the deal were not disclosed, but the federal government will partially fund the company’s future work on Covid vaccines, including the development of smaller dose vials and strain selection in line with Food and Drug Administration recommendations, Novavax said in its announcement.

Article Source: Washington Business Journal

The Morning Rundown

We’re staying up to the minute on the issues shaping the future. Join us on the newsletter of choice for Maryland politicos and business leaders. It’s always free to join and never a hassle to leave. See you on the inside.